THE EFFICACY OF (L)-2-OXOTHIAZOLIDINE-4-CARBOXYLATE (OTC) AND (L)-CYSTEINE IN REDUCING URINARY OXALATE EXCRETION

被引:5
作者
BAKER, PW [1 ]
BAIS, R [1 ]
ROFE, AM [1 ]
机构
[1] INST MED & VET SCI,DIV CLIN BIOCHEM,ADELAIDE,SA 5000,AUSTRALIA
关键词
CYSTEINE; CALCIUM OXALATE; KIDNEY CALCULI;
D O I
10.1016/S0022-5347(17)32339-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The effects of orally administered (L)-cysteine and (L)-2-oxothiazolidine-4-carboxylate (OTC) on urinary oxalate excretion were investigated in male Porton rats, as (L)-cysteine has been shown to form an adduct with glyoxylate in vitro. Feeding of OTC (204 +/- 1 mg.per day) for 5 days increased urinary cyst(e)ine, p < 0.001; sulphate, p < 0.001; phosphate, p < 0.05; and calcium, p < 0.05; and decreased urinary pH, p < 0.001. In addition, OTC feeding significantly decreased urinary oxalate excretion when compared with controls, p < 0.05 (Delta OTC-Delta Control -4.26 +/- 1.55 nmol./day/gm.). In the 5-day period after cessation of OTC feeding, all urinary parameters returned to control levels. At the completion of this recovery period there were no significant differences in any of the clinically significant plasma parameters. When fed for 22 days (191 +/- 3 mg. per day) OTC decreased urinary oxalate compared with controls, p < 0.05 (Delta OTC-Delta Control -9.47 +/- 4.24 nmol./day/gm.). Other urinary parameters (uric acid, magnesium, calcium, phosphate, creatinine, pH and volume) were not significantly altered by OTC feeding. Again, at the completion of this feeding period there were no significant differences in any of the clinically significant plasma parameters. (L)-cysteine feeding for 5 days (184 +/- 10 mg. per day) increased urinary sulphate, p < 0.001; and magnesium, p < 0.05, and decreased urinary pH, p < 0.001. In addition, (L)-cysteine feeding did not significantly change urinary oxalate excretion when compared with the controls (Delta(L)-Cysteine-Delta Control -2.94 +/- 2.14 nmol./day/gm.). However, at the completion of this feeding period, plasma urate, p < 0.02; and glucose, p < 0.05, were decreased, and plasma potassium, p < 0.01, was increased. These results indicate that orally administered OTC is effective in reducing urinary oxalate excretion without altering plasma biochemistry. It is suggested that (L)-cysteine-glyoxylate adduct formation is the mechanism by which OTC reduces urinary oxalate excretion through a reduction in endogenous oxalate production.
引用
收藏
页码:2139 / 2146
页数:8
相关论文
共 41 条
[1]   THE INHIBITION OF METABOLIC OXALATE PRODUCTION BY SULFHYDRYL COMPOUNDS [J].
BAIS, R ;
ROFE, AM ;
CONYERS, RAJ .
JOURNAL OF UROLOGY, 1991, 145 (06) :1302-1305
[2]   INHIBITION OF ENDOGENOUS OXALATE PRODUCTION - BIOCHEMICAL CONSIDERATIONS OF THE ROLES OF GLYCOLLATE OXIDASE AND LACTATE-DEHYDROGENASE [J].
BAIS, R ;
ROFE, AM ;
CONYERS, RAJ .
CLINICAL SCIENCE, 1989, 76 (03) :303-309
[3]   INVESTIGATIONS INTO THE EFFECT OF GLYOXYLATE DECARBOXYLATION AND TRANSAMINATION ON OXALATE FORMATION IN THE RAT [J].
BAIS, R ;
ROFE, AM ;
CONYERS, RAJ .
NEPHRON, 1991, 57 (04) :460-469
[4]   FORMATION OF THE L-CYSTEINE-GLYOXYLATE ADDUCT IS THE MECHANISM BY WHICH L-CYSTEINE DECREASES OXALATE PRODUCTION FROM GLYCOLATE IN RAT HEPATOCYTES [J].
BAKER, PW ;
BAIS, R ;
ROFE, AM .
BIOCHEMICAL JOURNAL, 1994, 302 :753-757
[5]   CALCIUM-OXALATE NEPHROLITHIASIS - DEFECTIVE OXALATE TRANSPORT [J].
BORSATTI, A ;
ROMBOLA, G ;
SURIAN, M ;
CALO, L ;
FABBRIS, A ;
VEZZOLI, G ;
CALDERARO, V ;
MASCHIO, G ;
BORGHI, L ;
BAZZATO, G ;
DESANTO, N ;
WILLIAMS, HE ;
MARANGELLA, M ;
COLUSSI, G ;
CAUDARELLA, R ;
KASSIRER, JP ;
TASCA, A ;
SCHENA, FP ;
DANGELO, A ;
MORACCHIELLO, P .
KIDNEY INTERNATIONAL, 1991, 39 (06) :1283-1298
[6]   SULFATE TRANSPORT IN RABBIT PROXIMAL CONVOLUTED TUBULES - PRESENCE OF ANION-EXCHANGE [J].
BRAZY, PC ;
DENNIS, VW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1981, 241 (03) :F300-F307
[7]   DIETARY INFLUENCE ON SERUM AND URINARY OXALATE IN HEALTHY-SUBJECTS AND OXALATE STONE FORMERS [J].
BUTZ, M ;
HOFFMANN, H ;
KOHLBECKER, G .
UROLOGIA INTERNATIONALIS, 1980, 35 (05) :309-315
[8]  
CALI JP, 1973, CLIN CHEM, V19, P1208
[9]   SPECTROPHOTOMETRIC DETERMINATION OF CYSTEINE AND CYSTINE IN URINE [J].
CHRASTIL, J .
ANALYST, 1990, 115 (10) :1383-1384
[10]   UPTAKE AND METABOLISM OF L-2-OXO-[S-35]THIAZOLIDINE-4-CARBOXYLATE BY RAT-CELLS IS SLOWER THAN THAT OF L-[S-35]CYSTEINE OR L-[S-35]METHIONINE [J].
COLOSO, RM ;
HIRSCHBERGER, LL ;
STIPANUK, MH .
JOURNAL OF NUTRITION, 1991, 121 (09) :1341-1348